Skip to content

Power During Functional Tasks in Older Adults

Power During Functional Tasks in Older Adults: Reliability, Reference Values and Relationship With Other Outcome Measurements Related to Sarcopenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04019132
Enrollment
284
Registered
2019-07-15
Start date
2020-01-20
Completion date
2022-03-01
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

Muscle Power, Functional capacity

Brief summary

The primary aim of this study is to optimize the methodology to measure lower limb power in older adults, so that clinicians are able to detect functional problems in this population earlier.

Detailed description

Aging is associated with slower movement patterns, a higher fall risk and a restriction in functionality. This will lead to an increase in the number of dependent elderly and a high socio-economic burden. From the age of 40, a systematic loss of muscle mass and muscle force, also known as sarcopenia, will occur. In addition, performing daily tasks requires the production of muscle force at a certain speed. The product of force and speed, power, decreases even earlier and faster than muscle force. This power is typically measured with specialized equipment, which limits the large-scale applicability. With the help of accelerometry there is the possibility to measure power during more functional tasks and movements, which benefits the applicability, but the reliability, reference values and link with other outcome measurements related to sarcopenia has to be investigated.

Interventions

DIAGNOSTIC_TESTMuscle function test

Body measurements, power and strength tests of the knee extensor muscle, handgrip strength, functional capacity tests, objective measurement of physical activity (subgroup of older adults, n=50)

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \>20

Exclusion criteria

* Unstable cardiovascular diseases * Fever or acute infection * Cognitive or physical malfunctioning that hinders the understanding or performance of tests and/or instructions

Design outcomes

Primary

MeasureTime frameDescription
Physical activity1 weekObjective measurement of physical activity in a subgroup of older participants (n=50) by means of accelerometry
Lower limb muscle power during a stair climb test1 test moment of approximately 1 hour, planned between September 2019 and July 2020The power (watt) needed to perform stair climbing is calculated using a 3D accelerometer (DynaPort MoveTest, McRoberts), worn at the back of the participant
Number of steps/stairs a day1 weekObjective measurement of physical activity in a subgroup of older participants (n=50) by means of accelerometry
Lower limb muscle power during a sit-to-stand test1 test moment of approximately 1 hour, planned between September 2019 and July 2020The power (watt) needed to perform 5 sit-to-stand transitions and a 30 sec. sit-to-stand test is calculated using a 3D accelerometer (DynaPort MoveTest, McRoberts), worn at the back of the participant
Reliability of power measurements measured with a 3D accelerometer1 test moment of approximately 30 minutes, planned between September 2019 and July 2020Reliability of power measurements (watt) measured with a 3D accelerometer (DynaPort MoveTest, McRoberts) worn during functional activities (stair climbing, sit-to-stand test) three times within a period of 2 weeks
Rate of power (force-velocity) development1 test moment of approximately 1 hour, planned between September 2019 and July 2020Participants perform a test protocol on a Biodex Dynamometer. The rate of power development (watt/s) is defined as the linear slope of the power-time curve and is measured from the onset of movement till peak power.
Handgrip strength1 test moment of approximately 1 hour, planned between September 2019 and July 2020Handgrip strength (kg) evaluated with a Jamar dynamometer
Jumping height1 test moment of approximately 1 hour, planned between September 2019 and July 2020Jumping height (in cm) measured during a standardized jump test

Secondary

MeasureTime frameDescription
6min walk distance1 test moment of approximately 1 hour, planned between September 2019 and July 2020The walk distance (in m) covered in 6 min.
Balance1 test moment of approximately 1 hour, planned between September 2019 and July 2020Number of seconds a participant can hold a tandem stand, a semi-tandem stand or with the feet together
Maximal gait speed1 test moment of approximately 1 hour, planned between September 2019 and July 2020The average speed to walk 3m as fast as possible (in m/s)
Usual gait speed1 test moment of approximately 1 hour, planned between September 2019 and July 2020The average speed to walk 4m at a usual pace (in m/s)
Maximal isometric strength1 test moment of approximately 1 hour, planned between September 2019 and July 2020Maximal strength (Nm) is measured by means of unilateral isometric knee-extensor tests on a Biodex Dynamometer
Maximal isokinetic strength1 test moment of approximately 1 hour, planned between September 2019 and July 2020Maximal strength (Nm) is measured by means of unilateral isokinetic knee-extensor tests on a Biodex Dynamometer
Number of repetitions during a 30s sit-to-stand test1 test moment of approximately 1 hour, planned between September 2019 and July 2020Number of complete sit-to-stand transitions in 30 sec.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026